Cardiac Monitoring and Heart Failure in Advanced Breast Cancer Patients Treated With Trastuzumab in Ontario, Canada

BACKGROUND: Trastuzumab has improved patient outcomes in HER2 + breast cancer (BC) but carries a risk of cardiotoxicity. Routine cardiac imaging is recommended for advanced breast cancer (aBC) patients during trastuzumab treatment despite a lack of evidence that this improves patient outcomes. This...

Descripción completa

Detalles Bibliográficos
Autores principales: Rushton, Moira, Kappel, Coralea, Lima, Isac, Tuna, Meltem, Pritchard, Kathleen, Hawken, Steven, Dent, Susan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9160194/
https://www.ncbi.nlm.nih.gov/pubmed/35665245
http://dx.doi.org/10.3389/fcvm.2022.850674

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9160194/
https://www.ncbi.nlm.nih.gov/pubmed/35665245
http://dx.doi.org/10.3389/fcvm.2022.850674

Ejemplares similares